24 HR paliperidone 1.5 MG Extended Release Oral Tablet [Invega]

RxCUI
866105
RxNorm name
24 HR paliperidone 1.5 MG Extended Release Oral Tablet [Invega]
Display name
24 HR paliperidone 1.5 MG Extended Release Oral Tablet [Invega]
Full name
24 HR paliperidone 1.5 MG Extended Release Oral Tablet [Invega]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
INVEGAPALIPERIDONEJanssen Pharmaceuticals, Inc.7b8e5b26-b9e4-4704-921b-3c3c0d1599162025-01-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 866105

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7b8e5b26-b9e4-4704-921b-3c3c0d15991624 HR paliperidone 1.5 MG Extended Release Oral Tablet [Invega]SBD43These highlights do not include all the information needed to use INVEGA ® safely and effectively. See full prescribing information for INVEGA ® . INVEGA ® (paliperidone) Extended-Release Tablets Initial U.S. Approval: 200620250131
7b8e5b26-b9e4-4704-921b-3c3c0d159916Invega 1.5 MG 24 HR Extended Release Oral TabletSY43These highlights do not include all the information needed to use INVEGA ® safely and effectively. See full prescribing information for INVEGA ® . INVEGA ® (paliperidone) Extended-Release Tablets Initial U.S. Approval: 200620250131
7b8e5b26-b9e4-4704-921b-3c3c0d159916INVEGA 1.5 MG 24HR Extended Release Oral TabletPSN43These highlights do not include all the information needed to use INVEGA ® safely and effectively. See full prescribing information for INVEGA ® . INVEGA ® (paliperidone) Extended-Release Tablets Initial U.S. Approval: 200620250131